Online supplementary material - Measurement of tralokinumab concentrations in serum and tear fluid of atopic dermatitis patients and the relationship with treatment response and ocular surface disease
- Detailed description of the successful development and validation of the LC-MS/MS method for measuring tralokinumab concentrations in in serum and tear fluid - Baseline characteristics
Institutions
- University Medical Center Utrecht (NL)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-06-02
- DOI
- https://doi.org/10.5281/zenodo.15576664
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00